The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Another fundraise, no doubt a big one this time with lots of warrants for mates. The last one at 14p I wonder if its the same this time. EXPECT sub 20p soon enough
The Company has arranged an equity capital raising, with existing sophisticated and institutional shareholders, and clients of Novum Securities Limited, of £2.0 million (AUD$3.7 million) before expenses, through the issue of 1,422,590,303 new fully paid ordinary shares (Placement Shares) at GBP 0.14 pence (0.259 AUD cents) per share (Placement). The Placement will be completed in one tranche by 12 January 2022.
is the director a wessell or weasel
wont be long before we here of the next fundraise, sub 20 no doubt.
I can sell all my holdings which is uncommon. They need the shares to get to 75%. Expect a big push over the coming days
chance of 10p, 30p , I'll take a gamble on that. For the first time in ages I could sell all my shares in one go. Interesting times ahead me thinks
added twice this morning but NT most of time. Agree big buyer in the background. Cant wait for the sellers to clear.
next week should be very interesting. is there a take over coming or will everyone be heading for the door at 2p or much higher considering they bought at 175 p.
if it delists you will still have the shares. just not as easy to trade them
over the next few months, Board, with the support of the Noteholders, expects Alex to effect a restructuring and refocusing of the business on its core real world patient data business unit, and work in partnership with the National Health Service and the Life Sciences community to develop and discover new medicines and improve patient outcomes through the analysis of anonymised real world patient data. Alex and the Noteholders have committed to take the business forward consistent with the mission and values of Sensyne and its leading standards in the ethical application of clinical AI to health data.
with 700 million shares to sell from 0.28, we could be here a while
12 million seller cleared. watch this move forward Monday. dropped from 10p
12 million seller cleared. watch this move forward Monday. dropped from 10p
droppeed from 10p, new chairman onboard
Exscientia Appoints Alex Snow, Founder of Oxford Innovation Sciences and Former CEO of Lansdowne Partners, as Deputy Chairman
Published: Dec 11, 2017
11 December 2017, Oxford and Dundee, UK
Exscientia, the innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is pleased to announce the appointment of Mr Alex Snow to its Board of Directors as Deputy Chairman. He brings significant strategic development and financial experience to the board.
Alex is an experienced investor, banker and entrepreneur, having previously founded Oxford Sciences Innovation (OSI) and raised more than £600 million to commercialise world-leading science originating at Oxford University.
should see some kind of correction to 6-7p if the volume continues today
still over 600 million shares to be sold onto the market.
possibly a take over target and change of business then
Just added again, now holding 500000k shares. Agree it was over sold and over the coming days it should retrace.
time to average down again i suppose.
way oversold, Massive chairman in place now. Going to be interesting from here onwards
look9ng forward to 6p being hit tomorrow. gap filled before next move north